Biotechnology

Call for submissions for the 6th edition of the SophI.A Summit, the annual event for academic and business research on artificial intelligence

* National and international  researchers and R&D leaders are invited to submit  their work for presentation as  a conference,  a poster or a demonstration. * The most promising communications  will be awarded  Special Prizes which include  grants of several thousand euros. SOPHIA ANTIPOLIS, ...

2023-04-25 22:05 2056

Emmes Applauded by Frost & Sullivan for Streamlining Clinical Trials and for Its Competitive Strategies

Emmes collaborates with pharmaceutical companies as strategic partners, providing one-stop clinical trial services, reducing costs, and accelerating development. SAN ANTONIO, April 25, 2023 /PRNewswire/ -- Frost & Sullivan researched the contract research organizations industry and, based on its...

2023-04-25 20:30 1722

Wellcome Leap & Temasek Trust Launch US$60M Dynamic Resilience Programme to Extend Health Spans

* Average human life expectancy has doubled from 35 to 70 years over the past century[1], but health spans (number of years spent in good health) have not correspondingly improved[2]   * Multimorbidity (multiple coexisting health conditions) poses an urgent challenge for global health service...

2023-04-25 20:03 1865

BIORCHESTRA Scientific Founder, Chairman, and Chief Executive Officer Joins the Republic of Korea (ROK) Official State Visit to the United States

* The Official State visit by the President of the Republic of Korea marks the 70th anniversary of the U.S.-ROK alliance, which is advancing peace, stability, and prosperity for the two countries, for theAsia-Pacific region, and globally * President Yoon Suk Yeol and First Lady Kim Keon Hee o...

2023-04-25 20:00 1506

I-Mab Announces Positive Outcome in Arbitration Relating to Agreements with Tracon

* Award is an important victory for I-Mab and its shareholders on multiple levels, ending the multi-year long dispute * Tribunal completely denied Tracon's groundless damages claim of over $200 million relating to I-Mab's next-generation bi-specific antibody assets and awarded no damages to T...

2023-04-25 13:46 1822

Biotech firm Gene Solutions: A promising picture for multi-cancer early detection in Southeast Asia

HO CHI MINH CITY, Vietnam, April 25, 2023 /PRNewswire/ -- In January 2023, Vietnam's Medical Genetics Institute & Gene Solutions  published their research paper on Cancer Investigation:Clinical validation of a ctDNA-based assay for multi-cancer detection: an interim r...

2023-04-25 12:00 2146

Ascentage Pharma Passes GMP Compliance Audit by EU QP with Zero Deficiency, in an Achievement Signaling Global Recognition of the Company's Quality Management System

SUZHOU, China and ROCKVILLE, Md., April 24, 2023 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced that it recently received a zero-deficiency repor...

2023-04-25 08:42 1848

A new super factory with 29 GMP grade production lines for gene and cell therapy was launched in Shanghai by OBiO technology

SHANGHAI, April 24, 2023 /PRNewswire/ -- On April 21, 2023, OBiO Technology ( Shanghai) Corp., Ltd. ("OBiO" or "the Company"), a leading gene and cell therapy CDMO inChina, announced the launching of a new GMP manufacturing base, named OBiO Intelli-M. The new base was located in theChina (Shang...

2023-04-24 22:36 3000

BMC H-80 series: empowering breathing solutions for breathing and oxygen therapy

BEIJING, April 24, 2023 /PRNewswire/ -- Recently, the H-80 series Respiratory High-Flow Therapy Device has added more comprehensive monitoring indicators for even greater convenience and efficiency to help people in respiratory failure.   April is a crucial month to prioritize the respiratory hea...

2023-04-24 20:00 1870

WuXi AppTec Continued Solid Growth in First-Quarter of 2023 On Top of an Exceptionally Strong Year of 2022

Revenue Up 5.8% Year-Over-Year to RMB8,964 Million Net Profit Attributable to Owners of the Company Up 32.0% Year-Over-Year to RMB2,168 Million Diluted Earnings per Share (EPS) Up 35.8% Year-Over-Year to RMB0.72 Adjusted Non-IFRS Net Profit Attributable to Owners of the Company Up 14.1% Year-Over-...

2023-04-24 18:03 2376

Samsung Biologics Reports First Quarter 2023 Financial Results

* Recorded Q1'23 consolidated revenue of KRW 720.9 billion. * Recorded Q1'23 consolidated operating profit of KRW 191.7 billion. * Expected to maintain a strong growth trajectory with the full utilization of existing and newly expanded capacities. INCHEON, South Korea, April 24, 2023 /PRNews...

2023-04-24 14:51 2279

Belief BioMed Announces a Key Milestone of Dosing Completion for All Subjects in its Registrational Clinical Trial of BBM-H901

SHANGHAI, April 24, 2023 /PRNewswire/ -- Belief BioMed Group (BBM), an industry-leading biotech company focusing on innovative gene therapies, announced today the completion of patient dosing in its Phase III Registrational Clinical Trial (CTR20212816) of BBM-H901, a gene therapy for Hemophilia ...

2023-04-24 10:23 2448

Bridge Biotherapeutics Receives FDA Authorization to Proceed with the First-in-Human Study of BBT-207, a 4th generation EGFR TKI

* The company has been notified by the FDA that the Phase 1/2 clinical trial may proceed * The latest preclinical data explored the antitumor efficacy and the intracranial activity of BBT-207 SEONGNAM, South Korea and CAMBRIDGE, Mass., April 23, 2023 /PRNewswire/ -- Bridge Biotherapeutics (KQ...

2023-04-24 10:00 1653

SCG Cell Therapy to Present Late-Breaking Data at the International Society for Cell & Gene Therapy (ISCT) Highlighting Promising Antitumor and Antiviral Activities of SCG101 in Treating HBV-Related Hepatocellular Carcinoma

SINGAPORE, April 24, 2023 /PRNewswire/ -- Singapore based SCG Cell Therapy Pte Ltd (SCG), a clinical-stage biotechnology company developing novel immunotherapies for infectious diseases and their associated cancers, today announced that late-breaking data from the company's TCR-T therapy pipeline...

2023-04-24 10:00 2325

Earth Day: Angel Yeast Sets Out Green Manufacturing Roadmap, advancing sustainable development

SHANGHAI, April 22, 2023 /PRNewswire/ -- In honor of Earth Day, Angel Yeast (SH600298), the world's leading yeast manufacturer, is accentuating its expanded commitment to building a conservation-oriented, environmentally friendly enterprise and contributing to achieving the "Dual Carbon" goals t...

2023-04-22 20:00 7535

For Earth Day 2023, Tianlong Champions the Safeguarding of Food Safety with Its Biolum Portable ATP Hygiene Monitoring System

XI'AN, China, April 21, 2023 /PRNewswire/ -- Tianlong , an innovative high-tech company specializing in molecular diagnostic products, is rallying around this year's Earth Day theme,Invest In Our Planet, which falls onApril 23, 2023, highlighting the vital importance of in...

2023-04-21 20:43 16027

ITRI Took Home Three Edison Awards(TM) in 2023

HSINCHU, April 21, 2023 /PRNewswire/ -- The highly-anticipated 2023 Edison Awards™ winners were revealed in Fort Myers, Florida , and the Industrial Technology Research Institute (ITRI ) is proud to be among them. The ITRI team attended the awa...

2023-04-21 19:27 3147

ImmVira Appoints Dr. Oliver Kong as Chief Medical Officer

SHENZHEN, China, April 20, 2023 /PRNewswire/ -- On April 17, 2023, ImmVira announced the appointment of Dr.Oliver Kong as Chief Medical Officer (CMO). Dr. Kong will be fully in charge of global clinical development and international collaboration of company pipelines, and participate in overall c...

2023-04-21 09:06 2122

CARsgen's CAR T-cell Candidate CT041 Achieves IND Clearance from the NMPA for the Postoperative Adjuvant Therapy of Pancreatic Cancer

SHANGHAI, April 20, 2023 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors, announced that CT041, an autologous CAR T-cell product candidate against the p...

2023-04-20 20:50 2398

Veeva Pulse Reveals Digital Content More Than Twice as Effective in Driving Promotional Response Globally

Significant opportunity for biopharmas as only 39% of HCP meetings across the globe today present digital content SINGAPORE, April 20, 2023 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today released the latest Veeva Pulse Field Trends Report

2023-04-20 16:23 3726
1 ... 110111112113114115116 ... 307

Week's Top Stories